Effect of coenzyme Q10 supplements on blood sugar and metabolic markers in obese, overweight patients with pre-diabetes in a hospital”

Effect of CoQ10 supplementation on glycemic and metabolic markers in Prediabetic Obese Patients in A Tertiary Care Hospital: A Double Blind, Randomized, Placebo Controlled Trial - nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/11/096897

Enrollment

Registered

2025-11-04

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases

Interventions

Intervention1: CoQ10: CoQ10 supplementation in prediabetic obese patients will lead to significant improvements in metabolic parameters, ultimately leading to improved health outcomes in the target po

Eligibility

Inclusion criteria

Inclusion criteria: PREDIABETIC , OBESITY

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
•Improvement in prediabetic state by estimating FBS, PPBS and HbA1c.Timepoint: •at 12 weeks	—

Secondary

Measure	Time frame
Improvement in insulin resistance by estimating TyG index, TG/HDL C ratio from baseline to 12 weeks Improvement in leptin adiponectin levels Improvement in Quality of life assessed by questionnaire Shortform Health Survey SF36 Timepoint: baseline to 12 weeks	—

Countries

India

Contacts

Public ContactDr Sai Sankavi R

SRM HOSPITAL GENERAL MEDICINE OPD

ss4838@srmist.edu.in9597908321

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026